RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis AI Analysis of TGTX
Powered by GPT-4o
Stock Analysis
Risk Assessment
Trading Strategy
PDF

Green day on Thursday for TG Therapeutics stock after gaining 0.119%
(Updated on Sep 19, 2024)

Buy or Hold candidate since Aug 06, 2024 Gain 22.84%

The TG Therapeutics stock price gained 0.119% on the last trading day (Thursday, 19th Sep 2024), rising from $25.25 to $25.28. It has now gained 6 days in a row. It is not often that stock manage to gain so many days in a row, and falls for a day or two should be expected. During the last trading day the stock fluctuated 4.01% from a day low at $25.09 to a day high of $26.09. The price has risen in 8 of the last 10 days and is up by 17.8% over the past 2 weeks. Volume fell on the last day by -450 thousand shares and in total, 4 million shares were bought and sold for approximately $96.46 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 30.47% during the next 3 months and, with a 90% probability hold a price between $26.70 and $35.78 at the end of this 3-month period.

TGTX Signals & Forecast

The TG Therapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $24.36 and $22.52. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, September 05, 2024, and so far it has risen 17.80%. Further rise is indicated until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for TG Therapeutics stock

TG Therapeutics finds support from accumulated volume at $25.19 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.01 between high and low, or 4.01%. For the last week, the stock has had daily average volatility of 5.66%.

Since the TG Therapeutics has been rising for 6 days in a row, the risk over the next couple of days has increased. We don't expect a major reaction as the stock is in very good shape technically, and therefore hold a positive evaluation despite the very short term risk.

Our recommended stop-loss: $24.13 (-4.55%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 22 days ago.)

Trading Expectations (TGTX) For The Upcoming Trading Day Of Friday 20th

For the upcoming trading day on Friday, 20th we expect TG Therapeutics to open at $25.49, and during the day (based on 14 day Average True Range), to move between $23.92 and $26.64, which gives a possible trading interval of +/-$1.36 (+/-5.38%) up or down from last closing price. If TG Therapeutics takes out the full calculated possible swing range there will be an estimated 10.76% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $25.19, some $0.0900 (0.36%) from the current price of $25.28, our system finds the risk reward attractive.

Is TG Therapeutics stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for TG Therapeutics stock to perform well in the short-term.

Current score: 3.002 Buy Candidate Unchanged

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

Predicted Fair Opening Price

Predicted fair opening price on September 20, 2024 - $25.49 ( 0.81%). The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for TGTX

Fibonacci Support & Resistance Levels

Level Price
R3 26.49 4.79%
R2 26.11 3.27%
R1 25.87 2.33%
Price 25.28
S1 25.10 -0.708%
S2 24.86 -1.65%
S3 24.48 -3.16%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0 -
Price 25.28
S1 25.19 -0.356%
S2 22.08 -12.66%
S3 20.58 -18.59%

FAQ

What is the symbol for TG Therapeutics Stock and on which exchange is it traded?
The symbol for TG Therapeutics is TGTX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell TG Therapeutics Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for TG Therapeutics stock to perform well in the short-term.

How to buy TG Therapeutics Stock?
TG Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy TG Therapeutics Stock.

What's the current price of TG Therapeutics Stock?
As of the end of day on the Sep 19, 2024, the price of an TG Therapeutics (TGTX) share was $25.28.

What is the 52-week high and low for TG Therapeutics Stock?
The 52-week high for TG Therapeutics Stock is $26.27 and the 52-week low is $6.47.

What is the market capitalization of TG Therapeutics Stock?
As of the Sep 19, 2024, the market capitalization of TG Therapeutics is 3.854B.

When is the next earnings date for TG Therapeutics?
The upcoming earnings date for TG Therapeutics is Nov 06, 2024.
Click to get the best stock tips daily for free!

About TG Therapeutics

TG Therapeutics TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hodgkin lymphoma, chronic lymphocytic leukemia (CLL), and relapsing forms of multiple sclerosis; and Umbra... TGTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT